KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Equity Ratio (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 17 years of Equity Ratio data on record, last reported at 0.73 in Q4 2025.

  • For Q4 2025, Equity Ratio changed 0.05% year-over-year to 0.73; the TTM value through Dec 2025 reached 0.73, changed 0.05%, while the annual FY2025 figure was 0.73, 0.05% changed from the prior year.
  • Equity Ratio reached 0.73 in Q4 2025 per VRTX's latest filing, up from 0.7 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.78 in Q3 2022 and bottomed at 0.7 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.75, with a median of 0.76 recorded in 2021.
  • Peak YoY movement for Equity Ratio: increased 4.95% in 2021, then decreased 7.02% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.75 in 2021, then rose by 1.94% to 0.77 in 2022, then rose by 0.9% to 0.77 in 2023, then dropped by 5.84% to 0.73 in 2024, then fell by 0.05% to 0.73 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.73 in Q4 2025, 0.7 in Q3 2025, and 0.71 in Q2 2025.